Jean Jacques Bienaime - Mar 15, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 15, 2022
Transactions value $
-$3,447,014
Form type
4
Date filed
3/17/2022, 09:18 PM
Previous filing
Mar 14, 2022
Next filing
Apr 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +40.3K +11.9% $0.00 379K Mar 15, 2022 Direct F1
transaction BMRN Common Stock Tax liability -$3M -38.3K -10.11% $78.27 341K Mar 15, 2022 Direct
transaction BMRN Common Stock Tax liability -$449K -5.56K -1.63% $80.72 335K Mar 16, 2022 Direct
holding BMRN Common Stock 248K Mar 15, 2022 Shares held by Jean-Jacques Bienaime Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +58K $0.00 58K Mar 15, 2022 Common Stock 58K $78.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2022. Price not applicable.
F2 Option grant vests 12/36th on March 15, 2023 and 1/36th on the 15th day of each month thereafter.